Roche Win Boosts Case for Adding Chemo to Cancer Immunotherapy – Voice of America
Voice of America |
Roche Win Boosts Case for Adding Chemo to Cancer Immunotherapy
Voice of America Cancer doctors struggling to work out the best way to use modern immunotherapy drugs now have further evidence of the benefits of adding them to chemotherapy, despite earlier skepticism. News that Roche’s immune system-boosting drug Tecentriq … Roche reshuffles lung cancer immunotherapy market with positive clinical trial resultsSTAT Roche chemo-immunotherapy combo mets NSCLC Phase III endpointEuropean Biotechnology Roche gets $12 billion stock boost from positive cancer, hemophilia resultsReuters Endpoints News –Xconomy –BioPharma Dive all 35 news articles » |
Voice of America |
Roche Win Boosts Case for Adding Chemo to Cancer Immunotherapy
Voice of America Cancer doctors struggling to work out the best way to use modern immunotherapy drugs now have further evidence of the benefits of adding them to chemotherapy, despite earlier skepticism. News that Roche’s immune system-boosting drug Tecentriq … Roche reshuffles lung cancer immunotherapy market with positive clinical trial resultsSTAT Roche gets $12 billion stock boost from positive cancer, hemophilia resultsReuters UPDATED: Roche shares surge as a double-shot win in I/O and hemophilia raises blockbuster expectationsEndpoints News Xconomy –BioPharma Dive –Nasdaq all 35 news articles » |
Singularity Hub |
You’ve Heard All About CRISPR Gene Editing—Here’s How It Works
Singularity Hub Gene editing is in the news a lot these days, but what is it exactly? Gene editing is the process of making precise and permanent changes to living things at the level of DNA, or more specifically, to the four molecular building blocks of DNA. Though … CRISPR Caught In The ActAsian Scientist Magazine Can gene tweaking lower our cholesterol? Using CRISPR and nanotechnology in miceGenetic Literacy Project |
Laboratory Equipment |
How a Poorly Explored Immune Cell May Impact Cancer Immunity, Immunotherapy
Laboratory Equipment The immune cells trained to fight off the body’s invaders can become defective. It’s what allows cancer to develop. So most cancer immunotherapy research has targeted these so-called effector T cells. But a new study steps back and considers: What if … |